<DOC>
	<DOCNO>NCT00542308</DOCNO>
	<brief_summary>Treatment , In combination BSC , Open-label , Single arm , Efficacy Study .</brief_summary>
	<brief_title>Zalutumumab Non-curable Patients With SCCHN</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>1 . Males females age â‰¥ 18 year 2 . Confirmed diagnosis , initially relapse , squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx , consider incurable standard therapy 3 . Failure least one course standard platinumbased chemotherapy 1 . Three prior chemotherapy regimens 2 . Prior treatment EGFr antibodies and/or EGFr small molecule inhibitor 3 . Past current malignancy SCCHN , except certain cancer disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>